Insider trades
Eydelman Mikhail, SVP of Vaxcyte PCVX, has filed 0 purchases and 59 sales on the open market. The latest trade was on 25/03/05.
Eydelman Mikhail
SVP, Gen Counsel & Corp Sec
- Company
- Vaxcyte PCVX
- First filing
- 23/01/04
- Trades
- 113 trades
- Buys / sales
- 0 / 59
- 12-month net buying
- No record
- Last trade
- 25/03/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 25/03/05 | 25/03/07 | 5,000 sh3 trades | $70.74avg. | $353,713.32 | −10.7% | |
| Open-market sale10b5-1 plan | 25/02/05 | 25/02/07 | 5,000 sh5 trades | $90.07avg. | $450,370.32 | −15.1% | |
| Open-market sale10b5-1 plan | 25/01/06 | 25/01/07 | 5,000 sh3 trades | $85.58avg. | $427,918.77 | −15.1% | |
| Open-market sale10b5-1 plan | 24/12/05 | 24/12/09 | 5,000 sh3 trades | $91.48avg. | $457,422.87 | −14.8% | |
| Open-market sale10b5-1 plan | 24/11/05 | 24/11/06 | 5,000 sh4 trades | $106.36avg. | $531,817.38 | −14.9% | |
| Open-market sale10b5-1 plan | 24/10/07 | 24/10/08 | 5,000 sh5 trades | $109.27avg. | $546,366.55 | −14.9% | |
| Open-market sale10b5-1 plan | 24/10/01 | 24/10/03 | 5,500 sh3 trades | $114.24avg. | $628,294.34 | −16.1% | |
| Open-market sale10b5-1 plan | 24/09/03 | 24/09/05 | 1,667 sh7 trades | $112.11avg. | $186,882.78 | −5.1% | |
| Open-market sale10b5-1 plan | 24/08/01 | 24/08/05 | 1,667 sh2 trades | $78.85avg. | $131,450.25 | −5.1% | |
| Open-market sale10b5-1 plan | 24/07/01 | 24/07/02 | 1,667 sh2 trades | $76.37avg. | $127,306.69 | −5.1% | |
| Open-market sale10b5-1 plan | 24/06/03 | 24/06/05 | 1,667 sh3 trades | $72.06avg. | $120,129.87 | −5.1% | |
| Open-market sale10b5-1 plan | 24/05/01 | 24/05/03 | 1,667 sh3 trades | $61.74avg. | $102,924.85 | −5.2% | |
| Open-market sale10b5-1 plan | 24/04/01 | 24/04/03 | 1,667 sh2 trades | $66.72avg. | $111,229.63 | −5.2% | |
| Open-market sale10b5-1 plan | 24/03/01 | 24/03/04 | 1,667 sh3 trades | $73.73avg. | $122,908.99 | −5.1% | |
| Open-market sale10b5-1 plan | 24/02/01 | 24/02/05 | 1,667 sh4 trades | $73.87avg. | $123,147.69 | −7.4% | |
| Open-market sale10b5-1 plan | 24/01/02 | 24/01/04 | 1,667 sh3 trades | $63.93avg. | $106,576.81 | −7.4% | |
VaxcytePCVX | Open-market sale10b5-1 plan | 23/12/07 | 23/12/11 | 10,000 sh | $56.50 | $565,000 | −32.2% |
| Open-market sale10b5-1 plan | 23/10/02 | 23/10/04 | 20,000 sh3 trades | $50.40avg. | $1,007,988.6 | −49.4% |